200 related articles for article (PubMed ID: 9884539)
1. Inactivation of pathogens in blood and blood products.
Ben-Hur E
Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539
[No Abstract] [Full Text] [Related]
2. Leukoreduction of the blood supply in Rhode Island.
Sweeney JD
Med Health R I; 1998 Dec; 81(12):386-91. PubMed ID: 9884537
[No Abstract] [Full Text] [Related]
3. Pathogen Reduction Technology in Transfusion: Where Do We Stand?
Khurshid M; Moiz B
J Coll Physicians Surg Pak; 2015 Nov; 25(11):779-80. PubMed ID: 26577959
[No Abstract] [Full Text] [Related]
4. Viral inactivation of blood components: recent advances.
Horowitz B; Ben-Hur E
Transfus Clin Biol; 1996; 3(1):75-7. PubMed ID: 8640317
[No Abstract] [Full Text] [Related]
5. Pathogen-reduction systems for blood components: the current position and future trends.
Seghatchian J; de Sousa G
Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
[TBL] [Abstract][Full Text] [Related]
6. [Blood transfusion safety].
Koistinen J
Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
[No Abstract] [Full Text] [Related]
7. [Can virus safety of blood products be assured?].
Krusius T
Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931
[No Abstract] [Full Text] [Related]
8. [The responsibility of the physician prescriber of blood products].
Hergon E; Quaranta JF; Moutel G; Hervé C; Rouger P
Transfus Clin Biol; 2004 Oct; 11(4):221-7. PubMed ID: 15564105
[TBL] [Abstract][Full Text] [Related]
9. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.
Goodrich RP; Edrich RA; Li J; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):5-17. PubMed ID: 16935562
[TBL] [Abstract][Full Text] [Related]
10. Is old blood bad blood?
Rao SV; Califf RM
Am Heart J; 2010 May; 159(5):710-2. PubMed ID: 20435176
[No Abstract] [Full Text] [Related]
11. Update of pathogen reduction technology for therapeutic plasma.
Chakrabarty P; Rudra S; Hoque MM
Mymensingh Med J; 2010 Apr; 19(2):308-11. PubMed ID: 20395932
[TBL] [Abstract][Full Text] [Related]
12. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
13. [Transfusions of older blood products may pose a risk. Knowledge of storage and transfusion-related injuries is unclear].
Tornqvist F; Ivarsson KE; Fransson MD; Schmidt-Melbye AC; Algotsson L; Schött U
Lakartidningen; 2012 Apr 4-10; 109(14-15):754-7. PubMed ID: 22611880
[No Abstract] [Full Text] [Related]
14. Frozen blood transfusion practices: time for change.
Isbister JP
Intern Med J; 2008 Sep; 38(9):683-5. PubMed ID: 19143885
[No Abstract] [Full Text] [Related]
15. Virus inactivation of fresh plasma.
Mohr H
Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
[No Abstract] [Full Text] [Related]
16. Bacterial contamination of blood products.
Palavecino E; Jacobs M; Yomtovian R
Curr Hematol Rep; 2004 Nov; 3(6):450-5. PubMed ID: 15496280
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.
Papin JF; Floyd RA; Dittmer DP
Antiviral Res; 2005 Nov; 68(2):84-7. PubMed ID: 16118025
[TBL] [Abstract][Full Text] [Related]
18. Pathogen inactivation: a new paradigm for blood safety.
McCullough J
Transfusion; 2007 Dec; 47(12):2180-4. PubMed ID: 18036073
[No Abstract] [Full Text] [Related]
19. [Rational substitution with stored blood and blood components].
Krüger KJ; Gürtler LG
Dtsch Med Wochenschr; 1995 Apr; 120(17):627-8. PubMed ID: 7736963
[No Abstract] [Full Text] [Related]
20. International blood collection and storage: clinical use of blood products.
Greening DW; Glenister KM; Sparrow RL; Simpson RJ
J Proteomics; 2010 Jan; 73(3):386-95. PubMed ID: 19664733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
